Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Kimberly-Clark will sell a majority of the unit to Brazil's Suzano, the big pulp producer. Winnebago Industries said it expects to adjust its headcount, shift production plans and post ...

Humana (HUM) backs reforms on extra Medicare Advantage payments from home visits and chart review. Read more here.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Real-time index price for Nasdaq Insurance Index (INSR), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

Per WSJ’s forecasting data, the average UNH price target is $378.86 per share. Given that the current UNH price is $292.80 ...

"It's really incredible growth across the platform." For its full fiscal year, Intuit said it expects to report revenue of $18.72 billion to $18.76 billion, up from the range of $18.16 billion to ...

Shares of health insurance company Humana (NYSE:HUM) fell 6.5% in the afternoon session after the Centers for Medicare & ...